Pericytes are important cellular components of the tumor microenviroment with established roles in angiogenesis and metastasis. These two cancer hallmarks are modulated by enzymes of the LOX family, but thus far, information about LOX relevance in tumor-associated pericytes is lacking. Here, we performed a comparative characterization of normal and tumoral pericytes and report for the first time the modulatory effects of LOX enzymes on activated pericyte properties. Tumoral pericytes isolated from childhood ependymoma and neuroblastoma specimens displayed angiogenic properties in vitro and expressed typical markers, including CD146, NG2, and PDGFRβ. Expression of all LOX family members could be detected in both normal and tumor-associated pericytes. In most pericyte samples, LOXL3 was the family member displaying the highest transcript levels. Inhibition of LOX/LOXL activity with the inhibitor β-aminopropionitrile (βAPN) significantly reduced migration of pericytes, while proliferation rates were kept unaltered. Formation of tube-like structures in vitro by pericytes was also significantly impaired upon inhibition of LOX/LOXL activity with βAPN, which induced more prominent effects in tumor-associated pericytes. These findings reveal a novel involvement of the LOX family of enzymes in migration and angiogenic properties of pericytes, with implications in tumor development and in therapeutic targeting tumor microenvironment constituents.
Introduction
It has been increasingly recognized that the multistep process of tumor development is driven not only by genetic modifications but also by nonmalignant stromal cells within the tumor microenvironment (TME), such as immune cells, endothelial cells, pericytes, and fibroblasts [1, 2] . In addition, extracellular matrix, growth factors, chemokines, and other TME components provide a critical communication network between stromal and tumor cells, impacting both tumor progression and efficacy of anticancer therapies [3] [4] [5] .
One important, albeit less studied, cellular component of the TME is the pericyte population [6] . Pericytes are present along the microvessel walls where they are important for vasculature remodeling, maturation and stabilization, regulation of blood flow, and blood vessel permeability. Multipotential differentiation capacity [7, 8] as well as immunomodulatory properties, particularly for central nervous system (CNS) pericytes, has also been reported for these cells [9, 10] .
Pericytes are closely attached to endothelial cells providing mechanical and physiological support [10] . The endothelial cell-pericyte communication is essential for regulating proliferation, migration, and differentiation of both cell types, which act in concert to coordinate angiogenesis [11] . During the normal vascular sprouting process, pericytes become activated, undergoing phenotypical and functional modifications. Pericyte activation involves enhanced cell migration, proliferation, and secretion of molecules such as proteases, which degrade the basement membrane and modulate the extracellular matrix structure [12, 13] .
In cancer, the tumor vascular structure does not achieve proper maturation and, as a consequence, has several abnormalities including irregular pericyte coverage [14] . Furthermore, tumor pericytes are loosely attached to the endothelium and present aberrant cytoplasmic projections invading the tumor parenchyma [13] . It is largely unknown whether mechanisms involved in pericyte activation are affected during tumor angiogenesis.
Recent studies have implicated lysyl oxidases (LOX) in vascular remodeling during angiogenesis [15] [16] [17] . This is an emerging role for the LOX family of secreted copperdependent amine oxidases, whose primary function is the covalent crosslinking of collagens and/or elastin in the extracellular matrix, maintaining tissue strength and structural integrity [18] . The LOX family is comprised of five members: LOX and LOX-like 1-4 (LOXL1-4), which also have important effects on cell senescence, differentiation, and migration [19] . Due to their role in extracellular remodeling, deregulation of enzymes of the LOX family is involved in different diseases [20] .
Several studies have extensively demonstrated expression of distinct LOX family members in various types of tumor cells, implicating their functions in tumor progression and metastasis [21, 22] . Despite the growing evidences of LOX contribution to the establishment of a protumorigenic microenvironment [23] , there is very few information available about tumor stroma-derived LOX [24, 25] . Thus far, expression of LOX family members in pericytes and LOX influence in pericyte protumorigenic properties have not been examined.
Here, we performed a comparative characterization of normal and tumor-associated pericytes and report for the first time the modulatory effects of LOX enzymes on activated pericyte properties directly implicated in tumor progression, namely migration, proliferation, and angiogenic activity.
Materials and Methods

Primary Cell Cultures.
Pericyte samples, NP-Ad (normal pericytes from adipose tissue) and NP-Mu (normal pericytes from muscle tissue), and mesenchymal stem cells (MSCs), PLAJ3 (adipose tissue) and UC3 (umbilical cord), were obtained, isolated, and cultivated as previously described [26, 27] . Primary cultures of tumor-derived pericytes, TPNbl (tumoral pericytes from neuroblastoma) and TP-Epn (tumoral pericytes from ependymoma), were obtained in collaboration with Dr. Hamilton Matushita from the Faculdade de Medicina, Universidade de São Paulo. Isolation and culture methods were conducted as described by Valadares et al. [26] . All procedures were approved by the institutional review board (CEP-IB number 121/2011), and informed consent was obtained from all donors. Human umbilical vein endothelial cells (HUVEC) were purchased directly from ATCC (Manassas, VA, USA) and cultivated under the same conditions as pericytes. 4 cells) were added to each well and incubated in a humidified 5% CO 2 atmosphere at 37°C. After 2 hours, the tubular networks were examined under the microscope and time-lapse captures were taken every 30 minutes for 24 hours using Incell Analyzer 2200 (GE Healthcare, Little Chalfont, UK). The obtained images were analyzed, and the total amount of lumens formed (considered as internal regions surrounded by cell cords), in three wells per experimental condition, was entirely counted using ImageJ software.
2.4. Expression of LOX Family Members. Total RNA was extracted and reverse transcribed as previously described [28] . Reactions of qRT-PCR were performed in triplicate using Power SYBR Green Master Mix (Life Technologies, Carlsbad, CA, USA) on Applied Biosystem 7500 Real-Time PCR System (Life Technologies). Expression of the housekeeping gene TBP was used as endogenous control. Quantitative analyses were based on a relative quantification curve, using MSC UC3 as a positive control sample. Primer with secondary antibody (anti-rabbit HRP-linked) and developed using ECL Chemiluminescence Detection System (GE Healthcare).
Inhibition of LOX/LOXL Activity. β-Aminopropionitrile
(βAPN) is commonly used to inhibit the activity of LOX enzymes since it acts as an active site inhibitor [22, 29] . Cells were pretreated with 1 μM βAPN for 24 hours before the assays. Additionally, βAPN was also added to the culture medium during all assay procedures at the same final concentration. The inhibition efficacy was verified by measuring H 2 O 2 after reaction with DCFH-DA (SigmaAldrich) in a flow cytometer, as described by Eruslanov and Kusmartsev [30] .
2.6. Cell Viability Assay. Cell viability was assessed by the MTT assay (Sigma-Aldrich). Briefly, cells at a density of 2 × 10 4 /mL were seeded into a 24-well plate and incubated at 37°C with 5% CO 2 humidified atmosphere for 24 hours. Cells were treated for 24, 48, and 72 hours with fresh medium containing 1 μM βAPN or vehicle (control). After treatment periods, MTT solution was added at concentration of 166.67 μg/mL and incubated for 4 hours at 37°C. The supernatant was discarded and formazan crystals were dissolved with DMSO. The optical density was measured at 550 nm using Epoch Microplate Spectrophotometer (BioTek, Winooski, VT, USA).
2.7. Cell Migration Assay. Cell migration assay was performed using modified Boyden chambers as described by Chen [31] . Briefly, 1 × 10 5 cells were plated at the upper compartment of a Transwell® with 8.0 μm pore polyester membrane insert (Corning) and medium with 10% FBS was placed at the inferior compartment to act as a chemoattractive solution. Following an incubation period (3 hours for tumor pericytes and 12 hours for normal tissue pericytes), the cells that migrated through the membrane were fixed and stained with 1% of toluidine blue and 1% borax solution. Stained cells were lysed with 1% SDS, and optical density was measured at 626 nm. Table 1 , tumor-associated pericytes displayed a rather heterogeneous pattern of expression of the typical pericyte markers, CD146, NG2, and PDGFRβ, compared with normal pericytes. However, as expected, both normal and tumor-associated pericyte populations were mainly negative for the expression of endothelial and hematopoietic cell markers and did not display the combined expression of CD90, CD73, and CD105, a required characteristic of mesenchymal stromal cells (MSCs) [32] . Further functional tube formation assays confirmed that all normal and tumorassociated pericyte cultures were comprised by cells capable of generating capillary-like structures in vitro (Figures 1(a) , 1(b), 1(c), and 1(d)), a characteristic property of pericytes and endothelial cells, but not of MSCs (Figures 1(e) and 1(f)). A more detailed analysis revealed that, under the same experimental conditions, tumor-associated pericytes presented significantly higher migration and proliferation rates compared with normal pericytes (Figures 2(a) and 2(b) ). When comparing the kinetics of tube formation in vitro (Figures 2(c) and 2(d) ), tumor-associated pericytes either generated a lower amount of total capillary-like structures or took a longer time to attain the maximum amount of such structures than normal pericytes, indicating an abnormal in vitro behavior.
Results
Abnormal Tumoral Pericyte Properties. As indicated in
Expression Profile of Lysyl Oxidases in Pericytes.
Since no previous studies were available regarding expression of LOX family members in pericytes, a LOX/LOXL expression profiling was carried out in the two normal tissuederived pericytes and two tumor-associated pericytes and compared with the expression levels detected in MSCs and endothelial cells, which are known to be positive for LOX/LOXL expression.
At the transcriptional level, a concordant LOX/LOXL expression pattern was detected in the two normal tissuederived pericytes analyzed. Expression of all LOX family members could be detected in these cells, with LOXL3 exhibiting the highest expression levels (Figures 3(a) and 3(b) ). A similar LOX/LOXL expression pattern was detected in the pericyte sample derived from ependymoma, but not in the other pericyte sample derived from neuroblastoma (Figures 3(c) and 3(d) ). In the latter case, LOXL1 displayed the highest expression levels, such as the one exhibited by MSCs (Figure 3(f) ).
Nonetheless, the LOX/LOXL expression profile detected in normal and tumor-associated pericytes differed from the one exhibited by endothelial cells, in which LOX and LOXL2 are the predominantly expressed family members (Figure 3(e) ).
Expression of LOX and LOXL3 in pericytes was also confirmed at the protein level. Higher LOX levels were detected in tumor-associated pericytes compared with normal pericytes (Figure 4 ). Upon inhibition of LOX/LOXL activity, a significant reduction in migration of both normal and tumor-associated pericytes was detected. Cell proliferation rates, however, were not altered under the same experimental conditions (Figures 5(a) and 5(b) ).
Tube formation dynamics in vitro by pericytes was also affected upon inhibition of LOX/LOXL activity ( Figure 6 ). Compared with control conditions, there was a significant reduction in the total number of lumens formed and, for some pericyte cultures, the kinetic curves were also slightly dislocated. The most prominent effects were observed in cultures of tumor-associated pericytes, where the time for reaching the maximum amount of capillary-like structures was longer after inhibition of LOX/LOXL activity.
Altogether, these results indicate that blocking activity of LOX family members may influence pericyte properties that are essential to their protumorigenic roles within the TME.
Discussion
Understanding pericyte properties is essential given the effects that these cells may exert within the TME [33] [34] [35] [36] [37] . Despite the lack of consensus in the current literature about definite criteria for pericyte identification, the selected normal and tumor-derived pericytes used in this study displayed in vitro angiogenic properties and expression of cellular markers typically reported for this type of cell [38] . Notably, expression of CD146, NG2, and PDGFRβ was somewhat reduced in the population of tumor-associated pericytes, in agreement with previous studies reporting variable expression of some of these markers in pathological conditions. In perivascular soft tissue tumors, a reduced expression of αSMA, CD146, and PDGFRβ in pericytes from malignant glomus tumors has been implicated in partial loss of pericytic differentiation [39] . In brain tumors, low expression of the NG2 proteoglycan in pericytes has been reported to affect their interaction with endothelial cells and disturb tumor vasculogenesis [40] .
Within the CNS, pericytes play key physiological roles with effects in brain angioarchitecture, blood-brain barrier, and neuroinflammation [41] [42] [43] . Pericytes may also affect tumor malignancy and clinical prognosis, particularly in CNS tumors that are highly vascularized [44, 45] . In the present study, the increased migration and proliferation rates observed for tumor-associated pericytes compared with normal pericytes are consistent with the TME context. Tumor stromal cells, including fibroblasts and endothelial cells, are known to be constantly activated, exhibiting enhanced migration and proliferative behavior [46, 47] . Mechanisms underlying tumoral pericyte activation are, however, still elusive.
A growing body of evidences indicates that processes relevant to tumor progression, such as angiogenesis and metastasis, are modulated by enzymes of the LOX family [21, 23, 48] . Although these two processes involve interaction with the tumor stroma, thus far, very little is known about LOX expression in cellular components of the TME, and data on LOX expression in pericytes is lacking. Here, both normal and tumor-derived pericytes were found to express all members of the LOX family of enzymes. At the transcript level, the pattern of LOX/LOXL expression observed was very similar among the pericyte samples, the exception being the neuroblastoma-derived pericytes in which LOXL1 was more highly expressed than the other family members.
Apart from its role in extracellular matrix modulation and implications in pathogenesis [49, 50] , no other functions are known for LOXL3, the family member that displayed the highest expression level in most pericyte samples. On the other hand, expression of LOX and LOXL2 has been frequently correlated with all stages of tumorigenesis. Secretion of LOXL2 by both stromal and tumor cells, for instance, is involved in fibroblast activation within the TME [51, 52] . Regarding LOX/LOXL expression in tumor stromal cells, a recent study with a mouse model of mammary tumor progression showed that LOX expressed by carcinomaassociated fibroblasts stimulates tumor cell intravasation into the vasculature and ensuing metastasis [23] .
The significant inhibition of migration and angiogenic properties of pericytes detected upon inhibition of LOX/ LOXL activity with the inhibitor βAPN is in agreement with a previous study reporting inhibition of tumor angiogenesis by βAPN treatment in vivo [53] . Since knockdown of LOX and LOXL2 has also been reported to inhibit motility and network-forming ability of endothelial cells [49] , expression of LOX/LOXL in both pericytes and endothelial cells is likely Significance level: * P < 0 05, * * P < 0 01, * * * P < 0 001, and * * * * P < 0 0001.
indispensable for proper angiogenesis. Interestingly, in the in vitro angiogenesis assays, the inhibitory effects of βAPN treatment were more pronounced in tumor-associated pericytes than in their normal counterparts, given that not only a lower amount of total tube-like structures was observed but also a longer time to achieve the peak of such structures. This result is in concert with the higher LOX protein levels detected in tumor-associated pericytes, encouraging preclinical studies addressing whether antiangiogenic approaches based on LOX/LOXL inhibitors may be designed to be preferentially harming to pericytes associated with the tumor vasculature.
Conclusions
In summary, our findings reveal a novel involvement of LOX/LOXL family of enzymes in migration and angiogenic properties of both normal and tumor-associated pericytes, supporting the exploration of LOX/LOXL inhibitors to target activation of pericytes within the TME.
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